Companies active in coronary stent market development

While coronary stents were first developed in the 1980s and have been on the commercial market (i.e., FDA approved) since 1994, the technologies and materials used to create the devices are improving every day. In addition, innovative technology is bringing new classes of devices (e.g., fully degradable stents) to market, technologies that grow the market and even expand stent therapy to new patient populations in some cases

Given the  demand to address restenosis, the existence of a robust base of interventional cardiologists, the drive to have a less invasive alternative to coronary artery bypass, the widespread availability of reimbursement for stents and other dynamics in support of the industry, the coronary stent market proliferated.  As coronary stent technologies have evolved, market shares have also trended from a fragmented bare metal stent market to control by a limited number of drug-eluting stent (DES) manufacturers to the steady introduction of new DES products taking market share to the advent of the newest stent technologies (bioabsorbable, various composite materials and hybrid technologies) and to (potentially) technologies like drug-eluting balloons that may obviate the need for stents.

As evidence of the robust state of development in this industry, below is a sampling of the companies active in coronary stent market development:

  • Aachen Resonance GmbH
  • Abbott Vascular
  • AdvanSource Biomaterials Corp.
  • Aeon Bioscience
  • Allvivo Vascular, Inc.
  • Amaranth Medical, Inc.
  • amg Vascular Products
  • Angiotech Pharmaceuticals, Inc.
  • Arterial Remodeling Technologies (ART)
  • Atrium Medical Corporation
  • Avantec Vascular
  • B. Braun Melsungen AG
  • Balton Ltd.
  • Bavaria Medizin Technologie GmbH
  • Bioabsorbable Therapeutics, Inc. (BTI)
  • Bioabsorbable Vascular Solutions
  • Biocompatibles International plc
  • BioRest, Ltd.
  • Bioring SA
  • Biosensors International PTE Ltd.
  • Biosync Scientific Pvt. Ltd.
  • Biotronik GmbH & Co. KG
  • Biotronik
  • Blue Medical Devices B.V.
  • Boston Scientific
  • Caliber Therapeutics, Inc.
  • Cappella Inc.
  • CardioMind, Inc.
  • CeloNova BioSciences, Inc.
  • CID (Carbostent and Implantable Devices) S.r.l.
  • Cinvention AG
  • Nano-Composite Systems
  • Conor Medsystems, LLC
  • Cook Medical Inc.
  • Cordis
  • CorNova, Inc.
  • Creganna Medical Devices
  • CV Therapeutics
  • Devax
  • DISA Vascular (Pty) Ltd.
  • DSM Biomedical
  • Elixir Medical Corporation
  • Esperion Therapeutics
  • Estracure
  • eucatech AG
  • EuroCor GmbH
  • evYsio Medical Devices ULC
  • Genesis Technologies, LLC
  • Gilead Inc.
  • Global Therapeutics
  • Goodman Co., Ltd.
  • Guidant
  • Hexacath
  • ICON Interventional (formerly ICON Medical Corp.)
  • InspireMD
  • InTek Technology
  • Invatec S.p.A.
  • ITGI Medical Ltd.
  • Johnson & Johnson
  • JW Medical Systems
  • Kaneka Corporation
  • Kyoto Medical Planning Co., Ltd.
  • Labcoat Ltd.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Lutonix, Inc.
  • Maxcor Lifescience, Inc.
  • Medinol Ltd.
  • MediVas, LLC
  • Medlogics Device Corporation
  • Medtronic Vascular
  • Merck & Co., Inc.
  • Miami Cardiovascular Innovations (MCVI)
  • Micell Technologies, Inc.
  • MicroPort Scientific Corporation
  • Minvasys
  • MIV Therapeutics Inc.
  • mNEMOSCIENCE GmbH
  • MoBeta, Inc.
  • NanoInterventions, LLC
  • Neovasc Inc.
  • Nexeon MedSystems, Inc.
  • Novartis International AG
  • Novartis Pharma
  • Occam International B.V.
  • Opto Circuits (India) Ltd.
  • OrbusNeich
  • Palmaz Scientific, Inc.
  • Pfizer Inc.
  • Picarus NV
  • PLC Medical Systems, Inc.
  • Possis Medical
  • Prescient Medical, Inc.
  • Relisys Medical Devices Ltd.
  • Resverlogix
  • REVA Medical, Inc.
  • Sahajanand Medical Technologies Pvt. Ltd.
  • Sanofi-Aventis
  • Shandong Weigao Group Medical Polymer Ltd.
  • Sorin (CID S.r.l.)
  • Stentys, S.A.S.
  • SurModics, Inc.
  • TerumoCorporation
  • TissueGen, Inc.
  • Translumina GmbH
  • TriReme Medical Inc.
  • Tryton Medical, Inc.
  • Vascular Concepts Ltd.
  • VasoTech, Inc.
  • X-Cell Medical, Inc.
  • Xtent, Inc. (pending dissolution)

These companies are addressed in the 2009 report #C245, "Worldwide Market for Drug-Eluting, Bare Metal and Other Coronary Stents, 2008-2017."

Leave a Reply